This antibody recognises Notch Homolog 2 (NOTCH2).
Purification
Sterile filtration.
Immunogen
Synthetic Peptide corresponding to Amino acid residues of human Notch 2 located near the N-terminal sequence of the Cleaved N Intracellular Domain (NICD).
Immunohistochemistry on Paraffin Sections (1/500). ELISA. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Format
Liquid
Buffer
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 0.01 % (w/v) Sodium Azide as preservative.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid cycles of freezing and thawing.
Storage
-20 °C
Storage Comment
Store vial at-20 °C prior to opening. Aliquot contents and freeze at-20 °C or below for extended storage. Centrifuge product if not completely clear after standing at room temperature.
Target
NOTCH2
(Notch 2 (NOTCH2))
Alternative Name
NOTCH2
Background
Notch is synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase (S1 cleavage) in the trans-golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form. Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved (S2 cleavage) by TNF-alpha converting enzyme (TACE) to yield a membrane-associated intermediate fragment called Notch extracellular truncation (NEXT). This fragment is then cleaved by presenilin-dependent gamma-secretase (S3 cleavage) to release the intracellular domain (NICD) from the membrane.Synonyms: Neurogenic locus notch homolog protein 2, Notch 2, hN2